MSL Leaders



	Search:

Treatment of Spasticity in Patients With Multiple Sclerosis

Sponsored by the Postgraduate Institute for Medicine

Release date: August 2006
Expiration date:August 2007
Estimated time to complete activity: 1 hour

This educational program is supported through an educational grant from Biogen IDEC and Elan Pharmaceuticals Inc.

One of the most distressing symptoms of multiple sclerosis (MS) can be the phenomenon of spasticity. Advances have been made in its treatment and control in recent years but many clinicians who treat MS may not be familiar with the intricacies of technologies, such as intrathecal baclofen and botulinum toxin. Additionally, a team approach to care can greatly enhance the care of patients with spasticity. Many disciplines play a role in its management, attendant ambulatory disability, and motor dysfunction.

Processor Speed: 1.4 GHz P3
Memory: 256 MB RAM (20 MB Available)
Operating Systems Supported: Windows 2000 / XP
Browsers Supported: Internet Explorer 5.5 or greater and Mozilla Firefox
Additional Requirements: Flash player 8.0 or greater
800x600 Resolution or Higher with 32-bit color
Connection Speed: 128 Kbps or better
Adobe Acrobat Reader 6.0 or greater.

Click here to review the complete CME information.


	Search: